Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI
France will take a stake in Sanofi's Opella through the Public Investment Bank (BPI), finance minister Antoine Armand said on ...
France says it has received assurances over sale of painkiller maker to US investment fund CD&R
The proposed sale turned into a real political issue because Opella's products include Doliprane, the best-selling medicine ...
Sanofi reaches deal on terms of sale of consumer health arm, say French government sources
Sanofi on Sunday reached an agreement on terms to sell a controlling stake in its consumer health unit Opella to U.S. private ...
Sanofi in Talks With French Government to Address Concerns on Opella Deal
Sanofi is in discussions with the French government to address concerns officials raised about a potential sale of a ...
BioSpace4d
As Sanofi Preps Consumer Healthcare Sale, Here’s a Look Back at Similar High-Profile Deals
When Sanofi announced last week that it plans to sell a 50% controlling stake of Opella, its consumer helath business, the ...
FiercePharma9d
Sanofi enters talks with private equity firm to sell controlling stake in consumer health unit Opella
With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a ...
France's PAI Partners Ups Bid for Sanofi's Consumer Health Division As French Government Hints Possible Regulatory Block
Sanofi is in talks with CD&R to sell a 50% stake in its consumer healthcare unit, Opella. PAI Partners raised its bid by 200 ...
PAI Partners Raises Offer For Sanofi's Consumer Health Biz Opella: Reports
A consortium led by French private equity firm PAI Partners has submitted an increased offer for Sanofi's (SASY) consumer health ...
CD&R Nears €15 billion Deal for Sanofi Consumer Health Unit
Clayton Dubilier & Rice is nearing a deal to acquire Sanofi’s consumer health unit for about €15 billion ($16.4 billion), in ...
Reuters3d
Sanofi 'surprised' by PAI Partners' raised bid for Opella unit
PARIS, Oct 17 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Thursday it was "surprised" by a renewed, higher offer for its consumer arm Opella from private equity firm PAI ...
Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI, Reuters reports
France will take a stake in Sanofi’s Opella through the Public Investment Bank, or BPI, finance minister Antoine Armand said on Sunday, confirming an information from Le Figaro ...
PAI Partners raises offer for Sanofi's consumer unit - reports
PAI Partners raises offer for Sanofi's consumer health unit, Opella, by €200 million and aims to keep key operations in ...